8-K 1 v128894_8k.htm
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C. 20549
 
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):
 
October 14, 2008
 
SCIVANTA MEDICAL CORPORATION
(Exact name of registrant as specified in charter)
 
Nevada
000-27119
22-2436721
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
     
215 Morris Avenue, Spring Lake, New Jersey
07762
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code: (732) 282-1620
 
___________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Section 8 - Other Information

Item 8.01. Other Events.

On October 14, 2008, Scivanta Medical Corporation issued a press release providing an update on the development of the Hickey Cardiac Monitoring System. A copy of the press release is attached hereto as Exhibit 99.1.

 
Section 9 - Financial Statements and Exhibits
 
Item 9.01.   Financial Statements and Exhibits.

 
(d)
Exhibits:
     
 
Exhibit
 
 
Number
Description
     
 
99.1
 
Press Release Re: Scivanta Medical Corporation Provides Update on the Development of the Hickey Cardiac Monitoring System
 
 
2
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
SCIVANTA MEDICAL CORPORATION
(Registrant)
 
   
By:
/s/ David R. LaVance
 
David R. LaVance
 
Chairman of the Board, President and
 
Chief Executive Officer
 

 
Date: October 14, 2008
 
 
 
3
 
 
EXHIBIT INDEX
 
 
Exhibit
 
Number
Description
   
   
99.1
Press Release Re: Scivanta Medical Corporation Provides Update on the Development of the Hickey Cardiac Monitoring System


 
 
4